Neurosearch

About:

Neurosearch is a biopharmaceutical company developing pharmaceutical agents for ion channel and central nervous system disorders.

Website: http://www.neurosearch.com

Top Investors: Johnson & Johnson Development Corporation

Description:

NeuroSearch (NEUR) is a Scandinavian biopharmaceutical company listed on the Nasdaq OMX Copenhagen A/S. The core business of the company covers the development of novel pharmaceutical agents, based on a broad and well-established drug discovery platform focusing on ion channels and central nervous system (CNS) disorders. A substantial share of the activities is partner financed through strategic alliances with Eli Lilly and Company, Janssen Pharmaceutica and GlaxoSmithKline (GSK), and a license collaboration with Abbott. In addition, NeuroSearch has a broad portfolio of preclinical drug candidates and holds equity interests in several biotech companies. The company has approximately 220 employees with activities in Ballerup and Gothenburg.